Latest Lead News

HMC Capital Limited reported a record FY25 profit of $265.2 million, driven by strategic acquisitions and growth in digital infrastructure and energy transition sectors. The company also declared a consistent dividend and strengthened its balance sheet with an increased undrawn debt facility.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Income Asset Management announces key board retirements and appointments set for November 2025, aiming to strengthen governance and accelerate growth.

Australian Strategic Materials has announced the vesting of over 400,000 performance rights granted to its Managing Director and senior executives, marking a key moment in executive remuneration and potential share dilution.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

Australian Bond Exchange Holdings has responded to ASX queries confirming the material impact of its involvement in the RBA's Project Acacia and acknowledged a director's breach of trading rules during a closed period.

Top Shelf International Holdings Limited has appointed voluntary administrators amid financial distress, with plans to continue trading while exploring sale or recapitalisation options. Shares remain suspended as the company seeks a path forward.

Dicker Data Limited has updated its dividend distribution announcement, revealing a fully franked ordinary dividend of AUD 0.11 per share and setting the Dividend Reinvestment Plan price at AUD 8.897. The update clarifies key details ahead of the September payment date.

JAYRIDE Group has secured its first enterprise SaaS client with Thailand’s GB Limousine, marking a pivotal shift to recurring revenue and enterprise-grade transport software.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

betr Entertainment has officially launched its all-scrip takeover offer for PointsBet shareholders, valuing shares above a rival cash bid and promising significant cost synergies.